OBX
Obsidian Therapeutics, Inc.Company Information
- Company Name
- Obsidian Therapeutics, Inc.
- CIK
- CIK0002130606
- Category
- <br>Emerging growth company
- Ticker: Exchange
- OBX: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- OBX
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -5.35%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|
| Assets Current | 0 | ||||||
Assets | |||||||
| Assets | 0 | ||||||
| Other Assets Noncurrent | 0 | ||||||
Liabilities | |||||||
| Liabilities Current | 0 | ||||||
| Other Liabilities Noncurrent | 0 | ||||||
| Commitments And Contingencies | 0 | ||||||
| Common Stock Value | 0 | ||||||
| Receivable From Shareholders Or Affiliates For Issuance Of Capital Stock | 0 | ||||||
Stockholders Equity | |||||||
| Stockholders Equity | 0 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | ||||||
| Retained Earnings Accumulated Deficit | 0 | ||||||
| Liabilities And Stockholders Equity | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | ||||||
| Common Stock Shares Authorized | 0 | ||||||
| Common Stock Shares Issued | 0 | ||||||
| Shares Outstanding | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialObsidian Therapeutics, Inc. (OBX) — SEC Financial Statements & Analysis
Obsidian Therapeutics, Inc. (OBX) is a pharmaceutical preparations company. Obsidian Therapeutics, Inc. trades on Nasdaq as: OBX. Obsidian Therapeutics, Inc. (OBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, On the balance sheet, Obsidian Therapeutics, Inc. maintains net debt of $0. Figures sourced from SEC EDGAR.
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Obsidian Therapeutics, Inc. in?
Obsidian Therapeutics, Inc. (OBX) operates in the Pharmaceutical Preparations industry.
What exchange does OBX trade on?
Obsidian Therapeutics, Inc. (OBX) trades on the Nasdaq.
When was Obsidian Therapeutics, Inc. (OBX)'s most recent SEC filing?
Obsidian Therapeutics, Inc. (OBX)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.